institutional investment

Stadium Capital Management increased LCI Industries stake by $7.66M in Q4. The RV components supplier reported $4.1B revenue with double-digit earnings growth and improved margins.

Windsor Advisory Group raises Worthington Enterprises stake by $4.32M to $19.2M as industrial company reports $1.3B sales, $284M adjusted EBITDA.

NexGen Energy stock surged 123% as Hancock Prospecting invested $7.3M, boosting stake to $83.66M amid February 2026 federal approval for flagship Rook I uranium project.

RTW Investments establishes $193M position in Apellis Pharmaceuticals despite 29% stock decline, betting on turnaround potential of $689M revenue-generating biotech.

RTW Investments purchases $116M stake in Cogent Biosciences, raising position to 2.7% of AUM amid 360% stock surge and anticipated 2026 FDA decision on lead drug.

Sio Capital Management invested $24.53 million in Organon ($OGN) at $6.03/share, betting on turnaround potential despite 61% annual decline. Company maintains flat 2026 guidance with $1.9B adjusted EBITDA.

Resolute Capital invested $11.74M in agribusiness firm ANDE, whose stock surged 53% annually. Strong cash generation across grain, ethanol, and renewables segments driving investor interest.

Hub Group shares fell 34% after accounting restatement, but Broad Bay Capital Management initiated a $30.42M stake, suggesting market overreaction.

Caesars Entertainment stock outperforms S&P 500 by 20 points amid digital segment acceleration. Digital revenue more than doubled year-over-year, though $12 billion debt and net losses persist.

Solana and Cardano emerge as top altcoin picks, with Solana offering high transaction speeds and Cardano emphasizing technical rigor and institutional adoption potential.

Land & Buildings acquires additional shares, raising Centerspace stake to 9.19% ($55.27M position) on Midwest apartment REIT's stable rental income strategy.

Webs Creek Capital invested $57.73M in oilfield equipment maker Cactus, making it their top 10% holding. The move signals confidence despite recent margin pressures.

EVR Research increased Sonoco stake by 170,000 shares worth $7M, betting on cyclical recovery despite 6-point underperformance versus S&P 500.

PayPay's successful $16 IPO debut on March 12, 2026, opening at $19, signals renewed investor appetite and could catalyze a wave of fintech offerings in the recovering market.

Tabor Asset Management invests $9.79 million in Mohawk Industries, signaling confidence in flooring recovery as housing cycle turns positive.

Kintayl Capital establishes major $10.5M position in Qorvo with 124,268 shares, betting on RF semiconductor recovery through automotive, defense, and connectivity diversification.

Solas Capital acquires $7.53M stake in Primo Brands, signaling confidence in water giant's 29% sales growth and 27% year-to-date stock appreciation.

Solas Capital acquired $5.59M stake in Euronet Worldwide as stock declined 30% YoY, despite company reporting $4.24B revenue and projecting 10-15% earnings growth.

Parkman Healthcare Partners invests $20M in EyePoint Pharmaceuticals as shares surge 93% annually ahead of mid-2026 Phase 3 data for retinal disease treatment DURAVYU.

Waystar's stock fell 32% over a year, but Blue Door Asset Management bought $11.49M in shares, betting on the healthcare software company's strong fundamentals: 17% revenue and 21% EBITDA growth.